National Bank of Canada’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
Other funds holding BPMC
PCM
UOC
National Bank of Canada's BPMC Position: Q2 2025 in Review
National Bank of Canada sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 1 share — an estimated $89 sold.
National Bank of Canada first reported a position in BPMC in Q2 2022 and held it in 2 quarters. The position peaked at $15K in Q2 2022. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.
- National Bank of Canada reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
- National Bank of Canada sold 1 Blueprint Medicines share in Q2 2025, an estimated $89.
- National Bank of Canada first reported a position in Blueprint Medicines in Q2 2022 and held it in 2 quarters.
- National Bank of Canada's Blueprint Medicines position peaked at $15K in Q2 2022.
- 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.
Based on National Bank of Canada's 13F filing for Q2 2025, filed 13 Aug 2025.